Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung.
Cappelaere
P
P
Guiochet
N
N
Bastit
P
P
Favre
R
R
Vanderburg
M
M
Goupil
A
A
Chauvergne
J
J
Thomas
D
D
Van Glabbeke
M
M
Armand
J P
JP
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D009944:Organoplatinum Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C023359:iproplatin